5.16BMarket Cap
LossP/E TTM
TVTX Balance Sheet
You can check out the annual or quarterly balance sheets of Travere Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing TVTX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Travere Therapeutics Inc Have?
In its most recent quarterly, Travere Therapeutics Inc had 78.36M in cash and cash equivalents.
How Much Are Travere Therapeutics Inc's Total Liabilities?
Travere Therapeutics Inc reported 490.36M in total liabilities as of the latest reported quarter, including 159.90M in current liabilities and 330.46M in non-current liabilities.
What Are Travere Therapeutics Inc's Total Assets?
As of the latest reported quarter, Travere Therapeutics Inc's total assets were 605.19M, consisting of 437.56M in current assets and 167.63M in non-current assets.
How Much Shareholders' Equity Does Travere Therapeutics Inc Have?
Travere Therapeutics Inc reported 114.83M in total shareholders' equity as of the latest reported quarter.